CLDX: Celldex Therapeutics Inc Kompaniya qiymatining sof foydaga nisbati
Celldex Therapeutics (CLDX) saraton va allergiyalarga qarshi kurashish uchun ilg'or monoklonal antitanalarni ishlab chiqadi va bunda mustahkam xalqaro logistika zanjirlaridan foydalanadi. Kompaniyaning P/E ko'rsatkichlari tebranishlari bozor kutganlarini tasdiqlaydi, bunda -7.80 belgisi baholash tahlili uchun asosiy metrika vazifasini o'taydi. Anthony Marucci'ning klinik sinovlarga pragmatik yondashuvi innovatsion terapiyalarni rivojlantirish uchun resurslarning samarali taqsimlanishini ta'minlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CLDX_-_Celldex-Therapeutics_-_PE-Multiple "CLDX: Celldex Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Celldex (CLDX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Celldex Therapeutics|CLDX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Celldex Corp|CLDX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Celldex Therapeutics, Inc.|CLDX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Celldex Therapeutics|Tezkor likvidlik ko‘rsatkichi celldex.com
- foyda va bozor multiplikatorlari tafsilotlari:
CLDX - Sof foyda|Kutilayotgan sof foyda Celldex Therapeutics|CLDX - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Celldex Therapeutics Inc|CLDX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Celldex Therapeutics, Inc.|CLDX - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun foyda Celldex Therapeutics|CLDX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi celldex.com|CLDX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Celldex Therapeutics
Kompaniyaning har tomonlama tahlili:celldex.com CLDX
Celldex Therapeutics (CLDX) kompaniyasining klinik ishlab chiquvchi sifatidagi o'ziga xos tabiati uning daromadlarini tartibga soluvchi qarorlarga bog'liq qiladi, bu esa klassik foyda baholashini xavf-xatarlarni tahlil qilish vositasiga aylantiradi. Kompaniyaning joriy P/E ko'rsatkichini tahlil qilish orqali investor sof foyda orqali bozor qiymatining qoplash muddatini aniqlaydi va biotexnologiya sektori uchun xos bo'lgan kassa oqimining yuqori noaniqligi sharoitida ortiqcha to'lovlarni yoki spekulyativ kapitalizatsiya premiumlarini aniqlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|Precigen Corp (PGEN) - Narx-foyda koeffitsiyenti|PHAR: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati nektar.com (NKTR)|Narxning foydaga nisbati Upstream Bio|Narxning foydaga nisbati ZBIO|Narxning foydaga nisbati Immunome Corp (IMNM)|Narxning foydaga nisbati GOSS (Gossamer Bio Corp.)|P/E multiplikatori KALV (KalVista Pharmaceuticals)|SEPN: Narx-foyda multiplikatori|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Savara Inc|RIGL (Rigel Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|Narx-foyda multiplikatori ANAB|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|Bozor narxining sof foydaga nisbati JBIO|P/E multiplikatori ACRS (Aclaris)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cabalettabio.com|Ventyx Biosciences, Inc. (VTYX) - Narxning foydaga nisbati|Theratechnologies, Inc. - Kompaniya qiymatining sof foydaga nisbati|AVTX (Avalo Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals, Inc|Narxning foydaga nisbati Agenus (AGEN)|CLYM: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning foydaga nisbati|ADAG: Narx-foyda koeffitsiyenti|IMA - P/E multiplikatori|STTK (shattucklabs.com) - Narx-foyda koeffitsiyenti|EQ: Bozor narxining sof foydaga nisbati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|Immunic Inc (IMUX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ATRA|Narx-foyda koeffitsiyenti inflarx.de IFRX|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|Biznesning o‘zini qoplash muddati Adicet Bio Inc. (ACET)|Celularity Corp - P/E multiplikatori|INmune Bio Inc (INMB) - Narx-foyda koeffitsiyenti|Barinthus Bio (BRNS) - Narxning foydaga nisbati|KZR (Kezar Life Sciences Inc) - Narxning foydaga nisbati|SABS (SAB Biotherapeutics) - P/E multiplikatori|Narx-foyda multiplikatori AKTX (akaritx.com)|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics)|q32bio.com - Narx-foyda multiplikatori|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA (Edesa Biotech Corp) - Kapitalizatsiyaning sof foydaga nisbati|iBio, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|Narxning foydaga nisbati HCW Biologics, Inc.|APVO: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|P/E multiplikatori GRI (GRI Bio)|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati REVB (Revelation Biosciences Corp)|INDP: P/E multiplikatori|SCNI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|IGM Biosciences - Narx-foyda koeffitsiyenti|P/E multiplikatori iteostherapeutics.com ITOS|OCEA - Narxning foydaga nisbati|TCBP (TC BioPharm (Holdings) Plc) - Narx-foyda multiplikatori|THRD: P/E multiplikatori
